thiabendazole has been researched along with EHS Tumor in 3 studies
Tresaderm: dermatologic soln containing dexamethasone, thiabendazole & neomycin sulfate
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thiabendazole (TBZ), a new nonspecific immunopotentiator, was evaluated in combination with Cytoxan in the therapy of a syngeneic murine fibrosarcoma." | 3.65 | Chemoimmunotherapy of a murine fibrosarcoma: critical factors for success of combined modality therapy. ( Hinchliffe, D; Lovett, EJ; Lundy, J; Schor, M, 1977) |
| "Thiabendazole (TBZ) appears to be an immunorestorative agent, demonstrating maximum immunopotentiation in the immunosuppressed host." | 1.26 | Immunomodulation with thiabendazole: a review of immunologic properties and efficacy in combined modality cancer therapy. ( Lovett, EJ; Lundy, J, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lundy, J | 3 |
| Lovett, EJ | 3 |
| Wolinsky, SM | 1 |
| Conran, P | 1 |
| Hinchliffe, D | 1 |
| Schor, M | 1 |
3 other studies available for thiabendazole and EHS Tumor
| Article | Year |
|---|---|
Immunomodulation with thiabendazole: a review of immunologic properties and efficacy in combined modality cancer therapy.
Topics: Animals; Cyclophosphamide; Dinitrochlorobenzene; Drug Therapy, Combination; Humans; Hypersensitivity | 1978 |
Immune impairment and metastatic tumor growth: the need for an immunorestorative drug as an adjunct to surgery.
Topics: Animals; Antibodies, Neoplasm; Antibody Specificity; Cytotoxicity, Immunologic; Female; Fibrosarcoma | 1979 |
Chemoimmunotherapy of a murine fibrosarcoma: critical factors for success of combined modality therapy.
Topics: Animals; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fibrosarcoma | 1977 |